価格表

在庫・価格 : 2024年05月02日 08時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human HMGB1/HMG-1 ELISA Kit (Colorimetric)
データシート
NBP2-62766 NOVノバス バイオロジカルス
Novus biologicals, LLC
1 kit ¥163,000
(未発注)
追加

在庫・価格 : 2024年05月02日 08時32分 現在

Human HMGB1/HMG-1 ELISA Kit (Colorimetric)

  • 商品コード:NBP2-62766
  • メーカー:NOV
  • 包装:1kit
  • 価格: ¥163,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Wu K et al. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients. Int Immunopharmacol 2020 Mar;80:106122
Wu K et al
2020/01/01
PubMed
2 Vannier AGL et al. Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder. Alcohol 2021 Sep;95:37-43
Vannier AGL et al
2021/01/01
PubMed
3 Sun B et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells 2021 02;10(2)
Sun B et al
2021/01/01
PubMed
4 Wei J et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection. Cell 2021 01;184(1):76-91.e13
Wei J et al
2021/01/01
PubMed
5 Chen R et al. HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon 2020 Dec;6(12):e05672
Chen R et al
2020/01/01
PubMed
6 Gaikwad S et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer"s disease and frontotemporal dementia. Cell Rep 2021 Jul;36(3):109419
Gaikwad S et al
2021/01/01
PubMed
7 Shi H et al. Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight 2021 09;6(17)
Shi H et al
2021/01/01
Applications: ELISA PubMed
  • No.: 1
  • 文献情報:
    Wu K et al. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients. Int Immunopharmacol 2020 Mar;80:106122
    Wu K et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Vannier AGL et al. Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder. Alcohol 2021 Sep;95:37-43
    Vannier AGL et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sun B et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells 2021 02;10(2)
    Sun B et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Wei J et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection. Cell 2021 01;184(1):76-91.e13
    Wei J et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Chen R et al. HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon 2020 Dec;6(12):e05672
    Chen R et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gaikwad S et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer"s disease and frontotemporal dementia. Cell Rep 2021 Jul;36(3):109419
    Gaikwad S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Shi H et al. Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight 2021 09;6(17)
    Shi H et al
    2021/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed